Quest Diagnostics (DGX)
NYSE:DGX
Want to see DGX full AI Analyst Report?
Earnings Data
Report Date
Jul 28, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
2.82Last Year’s EPS
2.62Same Quarter Last Year
Moderate Buy
Based on 12 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call reported broadly strong commercial and operational performance: double-digit volume growth, ~9% organic revenue growth, margin expansion on an adjusted basis, AI/automation-driven productivity gains, and raised full‑year guidance. Near-term headwinds include mix-driven revenue-per-requisition pressure from large collaboration ramps, lower Q1 cash flow, wage/weather/fuel cost impacts, Project Nova investment dilution, and ongoing regulatory/Medicare rate uncertainty. Overall, the positives (revenue/volume growth, EPS improvement, strategic partnerships and productivity gains) outweigh the described challenges.Company Guidance
Strong Revenue Growth
Consolidated revenues of $2.9 billion, up 9.2% year-over-year; consolidated organic revenue growth of 9.0% in Q1.
Volume Expansion
Total requisitions increased 10.9% year-over-year with organic volume up 10.8%; contribution from Fresenius Medical Care and Corewell Health was approximately 7% of organic volume (organic volume ex these relationships = 3.8%).
Improved Profitability and EPS
Reported operating income of $399 million (13.8% of revenues) vs $346 million (13.0%) prior year; adjusted operating income $447 million (15.4% of revenues) vs $406 million (15.3%); reported EPS $2.24 vs $1.94 prior year and adjusted EPS $2.50 vs $2.21 (adjusted EPS growth ~13%).
Raised Full-Year Guidance
Updated 2026 guidance: revenues $11.78B–$11.90B (growth 6.8%–7.8%); reported EPS $9.58–$9.78; adjusted EPS $10.63–$10.83; cash from operations ≈ $1.75B; capex ≈ $550M. Guidance excludes contributions from prospective M&A and expects operating margin expansion.
Consumer Channel Momentum
Direct-to-consumer (questhealth.com) grew strongly (management cited 'high‑20s' percentage growth); consumer partnerships produced even stronger growth, with robust double-digit customer repeat rates and demand for new profiles (Elite, autoimmune, hormone tests).
Advanced Diagnostics Outperformance
Double-digit revenue growth across key advanced diagnostics areas (brain health, cardiometabolic/endocrine, autoimmune, oncology, women’s health); AD-Detect Alzheimer's testing more than doubled year-over-year; growth in Lp(a) and ApoB testing following new AHA guidelines.
Operational Productivity Gains via AI and Automation
Productivity increases credited to automation and AI: 40% productivity improvement among customer service agents using AI triage; Quest AI Companion reached ~350,000 patient engagements since launch; Invigorate program targeted to deliver ~3% annual cost savings.
Strategic Collaborations and Capacity Investments
Key collaborations (Corewell Health Co-Lab, Fresenius Medical Care) driving volume and planned expansion (state-of-the-art lab in Southeast Michigan); capital plan includes ~$550M capex with significant portion toward esoteric lab capacity to support advanced diagnostics growth.
DGX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DGX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 21, 2026 | $196.31 | $205.04 | +4.45% |
Feb 10, 2026 | $190.42 | $204.46 | +7.37% |
Oct 21, 2025 | $188.72 | $183.00 | -3.03% |
Jul 22, 2025 | $164.24 | $175.88 | +7.08% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Quest Diagnostics (DGX) report earnings?
Quest Diagnostics (DGX) is schdueled to report earning on Jul 28, 2026, Before Open (Confirmed).
What is Quest Diagnostics (DGX) earnings time?
Quest Diagnostics (DGX) earnings time is at Jul 28, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DGX EPS forecast?
DGX EPS forecast for the fiscal quarter 2026 (Q2) is 2.82.